Prescient Therapeutics (ASX-PTX)
Live Investor Briefing
Register for an Upcoming Session
Please join Prescient Therapeutics CEO Steven Yatomi-Clarke for a special live investor briefing.
Date: Register for an Upcoming Session
In the session, Steven will discuss:
- The company’s promising pipeline of cancer treatments with two targeted therapies, cell therapy enhancements and CAR-T;
- Its work in the most exciting area of cancer research “next gen” CAR-T and its OmniCAR platform;
- Strong balance sheet with $20m in the bank following oversubscribed Share Purchase Plan and Placement.
This is a live and interactive session, you simply need an internet connection to participate. Don’t miss out, spots are limited – This is a FREE event.